Intermittent fasting may help adults with Crohn’s disease and overweight or obesity lose weight and reduce systemic inflammation and disease activity.Data from a randomized controlled trial showed ...

A genetics‑guided drug, compound 6, targets CARD9 to subtly calm gut inflammation in Crohn’s disease, pointing to safer, longer‑lasting, precision treatments.

At least seven million people worldwide suffer from the two major forms of inflammatory bowel disease.

The licensed IP package and data set provide Stoked Bio with the exclusive rights to develop and the scientific foundation to optimize Enterololin for human use. "This license agreement is a pivotal ...

NES ZIONA, Israel, Feb. 17, 2026 /PRNewswire/ -- Amorphical, a developer of nano-amorphous mineral-based pharmacologic agents, today announced that long-term data from its Phase 2 trial in moderate-to ...

Paula Sojo tells PEOPLE that early warning signs appeared long before her health crisis at 18 ...

Hispanic patients with inflammatory bowel disease (IBD) have varying disease patterns depending on their genetic ancestry, ...

A new clinical trial suggests that changing when you eat could make a meaningful difference for people living with Crohn’s ...

A recent study revealed that intermittent fasting may assist patients accomplish long-term remission from Crohn’s ...

News and commentary from the world of gastroenterology and hepatology ...

Paula Sojo tells PEOPLE she began sewing ostomy covers after her surgeries, transforming a medical device into an accessory ...